Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Osteosarcoma
>>
PARP Inhibitors
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Lynparza
(olaparib) / Merck (MSD), AstraZeneca
Talzenna
(talazoparib) / Pfizer
